Asset Details
Do you wish to reserve the book?
Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure
Do you wish to request the book?
Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure
2024
Overview
Patients with chronic and serious illnesses experience significant quality of life concerns. More research is needed to understand the impact of financial burden on patients with COPD, heart failure, and kidney failure. Patients with COPD, heart failure, or kidney failure completed a cross-sectional online survey using validated measures of financial burden (general financial strain as well as financial toxicity attributable to treatment), physical quality of life (symptom burden and perceived health), and emotional quality of life (anxiety, depression, and suicidal ideation). ANCOVA was used to examine whether financial strain and financial toxicity were associated with physical and emotional quality of life, while accounting for key covariates. Among 225 participants with COPD (n = 137), heart failure (n = 48), or kidney failure (n = 40), 62.2% reported general financial strain, with 34.7% experiencing financial toxicity attributable to treatments. Additionally, 68.9% rated their health as fair or poor, experiencing significant symptom burden including fatigue, dyspnea, and chest pain. Participants also reported clinically relevant levels of anxiety (55.1%), depression (52.0%), and suicidal ideation (21.8%). In the total sample, financial strain was associated with worse physical and emotional quality of life on all measures (all Ps < .001). Financial toxicity attributable to treatment was not associated with quality of life in the total sample or subsamples. Patients with COPD, heart failure, and kidney failure face significant financial, physical, and emotional burdens. Financial strain appears to undermine physical and emotional quality of life. Our study highlights the demand for interventions aimed at mitigating financial strain and toxicity experienced by individuals with chronic illnesses.
Publisher
Public Library of Science,Public Library of Science (PLoS)
Subject
/ Anxiety
/ Chronic obstructive pulmonary disease
/ Dyspnea
/ Emotions
/ Female
/ Financial Stress - psychology
/ Humans
/ Kidneys
/ Male
/ Medicine and Health Sciences
/ Pulmonary Disease, Chronic Obstructive - economics
/ Pulmonary Disease, Chronic Obstructive - psychology
/ Renal Insufficiency - economics
/ Renal Insufficiency - psychology
/ Surveys
/ Toxicity
